Lawmakers grill Mylan CEO over EpiPen steep price increases

Reuters: U.S. lawmakers on Wednesday blasted steep price increases for Mylan's EpiPen emergency allergy treatment as they grilled the company's Chief Executive Heather Bresch at a congressional hearing. The House Committee on Oversight and Government Reform called Bresch to testify after the company raised the list price for a pair of EpiPens to $600 compared with $100 in 2007, when it acquired the product.

Congressman Elijah Cummings, ranking Democrat on the committee, said Mylan "jacked up" the price of the life-saving product "to get filthy rich at the expense of our constituents."

Read article